To access this premium content, please sign up for a free account!
Tags: Biotech Special Report 2022, biotech stocks, FDA, IPO, Moderna, Pfizer, pre-clinical, private ownership
Has the Gabby Fed Gone Too Far in Its Transparency Push?
The central bank’s greater openness these days fuels risky behavior and thwarts flexibility, some say.
To access this premium content, please sign up for a free account!
Tags: Alan Greenspan, Ben Bernanke, fed funds rate, Federal Reserve, Financial Crisis, FOMC, G. William Miller, Janet Yellen, Jerome Powell, moral hazard, Pandemic, Paul Volcker, QE, rate increases
« Chinese Investors Are Pulling Away From Russia. Here’s Why That Matters